Nephros (NEPH) Gains from Investment Securities (2011 - 2026)
Nephros (NEPH) recorded quarterly Gains from Investment Securities of $42500.0 in Q1 2026, up 4150.0% quarter-over-quarter from $1000.0 in Q4 2025, and up 4150.0% on a YoY basis from $1000.0 in Q1 2025.
Nephros (NEPH) Gains from Investment Securities (2011 - 2026) Analysis & Trends
Nephros' Gains from Investment Securities history runs 15 years deep, the most recent figure standing at $42500.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 4150.0% year-over-year to $42500.0; the TTM figure through Mar 2026 stood at $42500.0 (up 6.25% YoY), while the FY2025 annual figure was $1.3 million, up 8.62% from the prior year.
- Gains from Investment Securities was $42500.0 for Q1 2026 at Nephros, up from $1000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $447065.0 in Q2 2023 to a low of -$17000.0 in Q4 2024.
- Historically, Gains from Investment Securities has averaged $65571.9 across 5 years, with a median of $14864.5 in 2022.
- The sharpest annual moves came in 2024 and 2026: Gains from Investment Securities sank 131.48% in 2024, then jumped 4150.0% in 2026.
- A 5-year view of Gains from Investment Securities shows it stood at -$3000.0 in 2022, then surged by 1900.0% to $54000.0 in 2023, then tumbled by 131.48% to -$17000.0 in 2024, then surged by 105.88% to $1000.0 in 2025, then surged by 4150.0% to $42500.0 in 2026.
- The last three Gains from Investment Securities figures came in at $42500.0 (Q1 2026), $1000.0 (Q4 2025), and $14729.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42,500.00 |
| Mar 31, 2026 | 42,500.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 14,729.00 |
| Sep 30, 2025 | 14,729.00 |
| Jun 30, 2025 | 58,961.00 |
| Jun 30, 2025 | 58,961.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | -17,000.00 |
| Dec 31, 2024 | -17,000.00 |
| Sep 30, 2024 | 85,198.00 |
| Sep 30, 2024 | 85,198.00 |
| Jun 30, 2024 | 85,198.00 |
| Jun 30, 2024 | 85,198.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 54,000.00 |
| Dec 31, 2023 | 54,000.00 |